Conference Presentation Details - Table of Contents
Sixth International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
Release Date: April 13, 2009| Mar 20-21, 2009, New York, NY
Table of Contents
Intravenous Chemotherapy
Eric L. Eisenhauer
Debate 2: Patients With Recurrent Advanced Ovarian Cancer Should Be Treated With Antiangiogenic Agents in Combination With Chemotherapy: CON
Paul Sabbatini
Debate 3: Secondary Surgical Debulking Is an Acceptable Option in Patients With Recurrent Platinum-Sensitive Ovarian Cancer: PRO
Larry Copeland
Debate 3: Secondary Surgical Debulking Is an Acceptable Option in Patients With Recurrent Platinum-Sensitive Ovarian Cancer: CON
J. Tate Thigpen
Debate 3: Secondary Surgical Debulking Is an Acceptable Option in Patients With Recurrent Platinum-Sensitive Ovarian Cancer: REBUTTAL
Larry Copeland
Clinical Implications of BRCA Testing
Beth Karlan
Overcoming Platinum Resistance
Stephen B. Howell
New Agents for Platinum-Resistant Disease
Robert Coleman
New Developments in the Biology of Endometrial Cancer
Eric L. Eisenhauer
Debate 4: All Patients at High Risk for Ovarian Cancer Should Undergo Routine Screening: PRO
Beth Karlan
Debate 1: Patients With Recurrent Cervical/Endometrial Cancer Should Be Treated With Cisplatin/Paclitaxel: PRO
Krishnansu S. Tewari
Debate 1: Patients With Recurrent Cervical/Endometrial Cancer Should Be Treated With Cisplatin/Paclitaxel: CON
Gillian Thomas
Debate 1: Patients With Recurrent Cervical/Endometrial Cancer Should Be Treated With Cisplatin/Paclitaxel: REBUTTAL
Krishnansu S. Tewari
Debate 2: Vaginal Cuff Brachytherapy Can Be Substituted for Pelvic Radiation Therapy in High-Intermediate–Risk Endometrial Cancer: PRO
Kaled Alektiar
Debate 2: Vaginal Cuff Brachytherapy Can Be Substituted for Pelvic Radiation Therapy in High-Intermediate–Risk Endometrial Cancer: CON
Marcus Randall
Debate 2: Vaginal Cuff Brachytherapy Can Be Substituted for Pelvic Radiation Therapy in High-Intermediate–Risk Endometrial Cancer: REBUTTAL
Kaled Alektiar
Debate 3: Systemic Therapy for All Uterine Cancers Should Be Paclitaxel/Carboplatin: PRO
Matthew Powell
Debate 3: Systemic Therapy for All Uterine Cancers Should Be Paclitaxel/Carboplatin: CON
J. Tate Thigpen
PARP Inhibitors
Deborah K. Armstrong
Novel Antiangiogenic Agents
Robert Coleman
EGFR Inhibitors
Deborah K. Armstrong
Novel Immunotherapy for Ovarian Cancer
George Coukos
HPV Vaccines
Thomas Herzog
Instructions for Participation
To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>
You will be asked to login
or create an account.